Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Drug Safety|July 7, 1999
Is there an increased risk of stroke associated with oral contraceptives?K Zeitoun, B R CarrUltrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 1, 1995
The role of color Doppler in diagnosis of endometriomasF Aleem, J Pennisi, K Zeitoun, et al.Molecular Endocrinology (Baltimore, Md.)|February 11, 1999
Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting elementK Zeitoun, K Takayama, M D Michael, et al.Seminars in Reproductive Endocrinology|June 14, 2000
Aromatase in aging womenS E Bulun, K Zeitoun, H Sasano, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|July 1, 1994
The characterization of flow signals from tubal and ovarian arteries using intraoperative continuous wave DopplerF Aleem, K Zeitoun, R Calame, et al.The Journal of Clinical Endocrinology and Metabolism|August 18, 2000
Progesterone receptor isoform A but not B is expressed in endometriosisG R Attia, K Zeitoun, D Edwards, et al.Fertility and Sterility|April 21, 1998
Treatment of severe postmenopausal endometriosis with an aromatase inhibitorK Takayama, K Zeitoun, R T Gunby, et al.Endocrine-Related Cancer|March 24, 2000
Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosisS E Bulun, K Zeitoun, K Takayama, et al.The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiolK Zeitoun, K Takayama, H Sasano, et al.Pageof 1